Back

Conclusion

10 May 2026 (15:13 - 15:15)
Organised by: Logo
Congress Presentation Part of: Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure Renal Failure and Cardiovascular Disease Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Harriette Van Spall

McMaster University, Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail
Introduction
Professor S. Anker (Berlin, DE)
Video
Presentation thumbnail
Non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease: current clinical trial evidence
Professor M. Cikes (Zagreb, HR)
Slides Video
Presentation thumbnail
Guideline recommendations for steroidal and non-steroidal MRAs in heart failure and cardio-kidney-metabolic disease
Doctor S. Zieroth (Winnipeg, CA)
Slides Video
Presentation thumbnail
Implementation of non-steroidal MRAs in clinical practice
Doctor H. Van Spall (Hamilton, CA)
Slides Video
Presentation thumbnail
Discussion

Access the full session

Session thumbnail
Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 15:13 CET
You may be interested in
thumbnail
Congress Session
Non-steroidal mineralocorticoid receptor antagonists: current role and implementation in the management of patients with heart failure
thumbnail
Congress Session
A new era in the management of patients with heart failure: the role of non-steroidal MRAs
thumbnail
Congress Session
From evidence to action: a case-based guide to using finerenone in heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources